Simultaneously, first-phase insulin response to a stepped intravenous glucose infusion improved and was normalized in individuals with type 2 diabetes, whereas first-phase insulin response did not change 8 weeks after surgery in individuals with normal glucose tolerance [143]. This evidence concerns the gene INS and type 2 diabetes mellitus.